These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19232340)

  • 1. PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects.
    Cushing DJ; Kowey PR; Cooper WD; Massey BW; Gralinski MR; Lipicky RJ
    Eur J Pharmacol; 2009 Apr; 607(1-3):167-72. PubMed ID: 19232340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans.
    Cushing DJ; Adams MP; Cooper WD; Zhang B; Lipicky RJ; Kowey PR
    Am J Cardiol; 2009 Oct; 104(8):1152-7. PubMed ID: 19801040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the cardiac electrophysiology and general toxicology of two formulations of intravenous amiodarone in dogs.
    Cushing DJ; Cooper WD; Gralinski MR; Lipicky RJ; Kudenchuk PJ; Kowey PR
    Cardiovasc Toxicol; 2009 Sep; 9(3):126-33. PubMed ID: 19554478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypotensive effect of intravenous amiodarone is sustained throughout the maintenance infusion period.
    Cushing DJ; Cooper WD; Gralinski MR; Lipicky RJ
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):358-61. PubMed ID: 19793107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cardiodepressant effects induced by bolus intravenous administration of amiodarone in rabbits.
    Lessa MA; Tibiriçá E
    Fundam Clin Pharmacol; 2005 Apr; 19(2):165-72. PubMed ID: 15810896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PM101: intravenous amiodarone formulation changes can improve medication safety.
    Souney PF; Cooper WD; Cushing DJ
    Expert Opin Drug Saf; 2010 Mar; 9(2):319-33. PubMed ID: 20074019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone.
    Somberg JC; Timar S; Bailin SJ; Lakatos F; Haffajee CI; Tarjan J; Paladino WP; Sarosi I; Kerin NZ; Borbola J; Bridges DE; Molnar J;
    Am J Cardiol; 2004 Mar; 93(5):576-81. PubMed ID: 14996582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of rapid bolus administration of aqueous amiodarone versus 10-minute cordarone I.v. infusion on mean arterial blood pressure in conscious dogs.
    Somberg JC; Cvetanovic I; Ranade V; Molnar J
    Cardiovasc Drugs Ther; 2004 Sep; 18(5):345-51. PubMed ID: 15717136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxypropyl-β-cyclodextrin impacts renal and systemic hemodynamics in the anesthetized dog.
    Rosseels ML; Delaunois AG; Hanon E; Guillaume PJ; Martin FD; van den Dobbelsteen DJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):351-9. PubMed ID: 23978386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects of intravenous amiodarone in humans].
    Sicart M; Besse P; Choussat A; Bricaud H
    Arch Mal Coeur Vaiss; 1977 Mar; 70(3):219-27. PubMed ID: 404978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of levosimendan during long-term amiodarone treatment in dogs.
    Papp JG; Pollesello P; Varró A; Végh A; Udvary E
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):27-32. PubMed ID: 16867167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T
    J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Hemodynamic Effects of Intravenous Amiodarone Formulations During the Maintenance Phase Infusion.
    Lindquist DE; Rowe AS; Heidel E; Fleming T; Yates JR
    Ann Pharmacother; 2015 Dec; 49(12):1317-21. PubMed ID: 26416947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Adverse effects of intravenous amiodarone in 5 dogs.
    Souney PF
    J Vet Intern Med; 2009; 23(6):1127; author reply 1128. PubMed ID: 19957389
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute amiodarone toxicity due to an administration error: could excipient be responsible?
    Masi S; de Cléty SC; Anslot C; Detaille T
    Br J Clin Pharmacol; 2009 Jun; 67(6):691-3. PubMed ID: 19076154
    [No Abstract]   [Full Text] [Related]  

  • 16. Negative inotropic and lusitropic effects of intravenous amiodarone in conscious rats.
    Salgado HC; Simões GM; Santana Filho VJ; Dias da Silva VJ; Salgado MC; Fazan R
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):870-5. PubMed ID: 17645632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology and toxicology of a new aqueous formulation of intravenous amiodarone (Amio-Aqueous) compared with Cordarone IV.
    Somberg JC; Cao W; Cvetanovic I; Ranade V; Molnar J
    Am J Ther; 2005; 12(1):9-16. PubMed ID: 15662287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of 2 intravenous amiodarone formulations in healthy participants.
    Cushing DJ; Adams MP; Cooper WD; Kowey PR; Lipicky RJ
    J Clin Pharmacol; 2009 Apr; 49(4):407-15. PubMed ID: 19246726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic profile of amiodarone during acute and long-term administration in patients with ventricular dysfunction.
    Remme WJ; van Hoogenhuyze DC
    Cardioscience; 1990 Sep; 1(3):169-76. PubMed ID: 2102806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotension produced by rapid intravenous administration of chloramphenicol in anaesthetised dogs.
    Sangiah S; Burrows GE
    Res Vet Sci; 1989 Jan; 46(1):62-6. PubMed ID: 2922508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.